Overview

Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics, the absolute bioavailability and the lung bioavailability of inhaled Glyco pMDI.
Phase:
Phase 1
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
Treatments:
Charcoal
Glycopyrrolate